UNIGE document Scientific Article
previous document  unige:36189  next document
add to browser collection

Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues

Published in Biochemical journal. 2007, vol. 405, no. 3, p. 597-604
Abstract Regulated secretion of EC (endothelial cell) vWF (von Willebrand factor) is part of the haemostatic response. It occurs in response to secretagogues that raise intracellular calcium or cAMP. Statins are cholesterol-lowering drugs used for the treatment of cardiovascular disease. We studied the effect of fluvastatin on regulated secretion of vWF from HUVEC (human umbilical-vein ECs). Secretion in response to thrombin, a protease-activated receptor-1 agonist peptide, histamine, forskolin and adrenaline (epinephrine) was inhibited. This inhibition was reversed by mevalonate or geranylgeranyl pyrophosphate, and mimicked by a geranylgeranyl transferase inhibitor, demonstrating that the inhibitory mechanism includes inhibition of protein geranylgeranylation. To investigate this mechanism further, calcium handling and NO (nitric oxide) regulation were studied in fluvastatin-treated HUVEC. Intracellular calcium mobilization did not correlate with vWF secretion. Fluvastatin increased eNOS [endothelial NOS (NO synthase)] expression, but NOS inhibitors failed to reverse the effect of fluvastatin on vWF secretion. Exogenous NO did not inhibit thrombin-induced vWF secretion. Many small GTPases are geranylgeranylated and some are activated by secretagogues. We overexpressed DN (dominant negative) Rho GTPases, RhoA, Rac1 and Cdc42 (cell division cycle 42), in HUVEC. DNCdc42 conferred inhibition of thrombin- and forskolin-induced vWF secretion. We conclude that, via inhibition of protein geranylgeranylation, fluvastatin is a broadspectrum inhibitor of regulated vWF secretion. Geranylgeranylated small GTPases with functional roles in regulated secretion, such as Cdc42, are potential targets for the inhibitory activity of fluvastatin.
Keywords Calcium/metabolismCells, CulturedEndothelial Cells/drug effects/metabolismFatty Acids, Monounsaturated/pharmacologyHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyIndoles/pharmacologyNitric Oxide/metabolismProtein PrenylationVon Willebrand Factor/secretion
PMID: 17472573
Full text
Article (Published version) (203 Kb) - public document Free access
(ISO format)
FISH, Richard et al. Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues. In: Biochemical journal, 2007, vol. 405, n° 3, p. 597-604. doi: 10.1042/BJ20070404 https://archive-ouverte.unige.ch/unige:36189

506 hits



Deposited on : 2014-04-29

Export document
Format :
Citation style :